Researcher.Life Logo

Atherosclerosis : Impact Factor & More

eISSN: 1879-1484pISSN: 0021-9150

Aims and Scope of Atherosclerosis

Atherosclerosis is a monthly peer-reviewed scientific journal established in 1970 and published by Elsevier. It is the official journal of the European Atherosclerosis Society and is affiliated with the International Atherosclerosis Society. Less

Key Metrics

CiteScore
8.7
Eigenfactor
0.01 - 0.05
H-Index
186
Impact Factor
5 - 10
SJR
Q1Cardiology and Cardiovascular Medicine
SNIP
1.45
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Atherosclerosis

Atherosclerosis Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER IRELAND LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1961
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Atherosclerosis ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Atherosclerosis

Preoperative proprotein convertase subtilisin/kexin type 9 inhibitors versus statins and postoperative adverse events in hyperlipidemia: A nationwide, active-comparator cohort study
  • 1 Jun 2026
  • Atherosclerosis
Organoid models reveal mechanistic connections and sirolimus efficacy in liver-vascular steatosis and foam cell formation.
  • 8 May 2026
  • Atherosclerosis
Joint associations of the systemic inflammation response index and albumin-globulin ratio with all-cause and cardiovascular mortality across cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study in the UK Biobank.
  • 8 May 2026
  • Atherosclerosis
Urinary orosomucoid and the risk of cardiovascular events and all-cause mortality in the general population. The Tromsø Study 2007-2021.
  • 7 May 2026
  • Atherosclerosis
Reply to "Reconsidering the role of liver transplantation in homozygous familial hypercholesterolaemia: beyond last-resort therapy".
  • 7 May 2026
  • Atherosclerosis
Association between remnant cholesterol and peripheral artery disease from multiple perspectives.
  • 6 May 2026
  • Atherosclerosis
Preoperative proprotein convertase subtilisin/kexin type 9 inhibitors versus statins and postoperative adverse events in hyperlipidemia: A nationwide, active-comparator cohort study
  • 1 Jun 2026
  • Atherosclerosis
Organoid models reveal mechanistic connections and sirolimus efficacy in liver-vascular steatosis and foam cell formation.
  • 8 May 2026
  • Atherosclerosis
Joint associations of the systemic inflammation response index and albumin-globulin ratio with all-cause and cardiovascular mortality across cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study in the UK Biobank.
  • 8 May 2026
  • Atherosclerosis
Urinary orosomucoid and the risk of cardiovascular events and all-cause mortality in the general population. The Tromsø Study 2007-2021.
  • 7 May 2026
  • Atherosclerosis
Reply to "Reconsidering the role of liver transplantation in homozygous familial hypercholesterolaemia: beyond last-resort therapy".
  • 7 May 2026
  • Atherosclerosis
Association between remnant cholesterol and peripheral artery disease from multiple perspectives.
  • 6 May 2026
  • Atherosclerosis

FAQs on Atherosclerosis